A successful treatment for thyroid cancer is strictly correlated with an active Sodium Iodide Symporter (SLC5A5; NIS), which allows the retention of radioiodine in the tumor cells, leading to cell death. The gene discussed is SLC5A5; the disease is thyroid gland carcinoma.